Innovation and technology : adoption in health care markets /
"Anupam B. Jena and Tomas J. Philipson argue that further use of cost-effectiveness analysis to curb health care spending may do more harm than good. The twentieth century brought tremendous advances in health care technology, from antibiotics to laparoscopic surgery to targeted therapies for c...
Saved in:
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
Washington, D.C. :
AEI Press,
[2008]
|
| Series: | American Enterprise Institute library.
|
| Subjects: | |
| Online Access: | HeinOnline American Enterprise Institute Library |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000cam a2200000 i 4500 | ||
|---|---|---|---|
| 001 | ccn00950604 | ||
| 006 | m fo d f | ||
| 007 | cr bn nnnauuuu | ||
| 008 | 200929s2008 dcua ob 000 0 eng d | ||
| 040 | |a NjRocCCS |b eng |e rda |c NjRocCCS | ||
| 100 | 1 | |a Jena, Anupam B., |e author. | |
| 245 | 1 | 0 | |a Innovation and technology : |b adoption in health care markets / |c Anupam B. Jena and Tomas J. Philipson. |
| 264 | 1 | |a Washington, D.C. : |b AEI Press, |c [2008] | |
| 264 | 2 | |a [Getzville, New York] : |b William S. Hein & Company, |c [2020] | |
| 300 | |a 1 online resource (xv, 98 pages) : |b illustrations. | ||
| 336 | |a text |2 rdacontent | ||
| 337 | |a computer |2 rdamedia | ||
| 338 | |a online resource |2 rdacarrier | ||
| 490 | 1 | |a HeinOnline American Enterprise Institute library | |
| 504 | |a Includes bibliographical references (pages 91-95). | ||
| 520 | |a "Anupam B. Jena and Tomas J. Philipson argue that further use of cost-effectiveness analysis to curb health care spending may do more harm than good. The twentieth century brought tremendous advances in health care technology, from antibiotics to laparoscopic surgery to targeted therapies for cancer--but these gains have been expensive. Governments are struggling to control burgeoning expenditures without compromising the quality of health care. Increasingly, these efforts have relied on "cost-effectiveness analysis" that balances costs against patient benefits to determine which treatments will qualify for reimbursement. Is the use of cost-effectiveness analysis to guide technology adoption wise? Although reimbursement criteria may satisfy government health budgets today, they threaten to stifle the innovation that will generate new breakthroughs in health care technologies tomorrow. Such criteria benefit current patients by lowering the cost of health care in the short term, but they also hurt future patients by limiting producers' incentives for further medical innovation. Developers of drugs to treat HIV/AIDS, for example, earn lifetime profits equal to only 5 percent of the estimated $1.4 trillion social value of their treatments. How can policymakers reward innovators adequately--and thereby secure the welfare of future patients--while ensuring that current patients have access to much-needed new treatments? -- provided by publisher. | ||
| 588 | |a Description based on PDF title page, viewed September 29, 2020. | ||
| 650 | 0 | |a Medical innovations |x Cost effectiveness. | |
| 655 | 0 | |a Electronic books. | |
| 700 | 1 | |a Philipson, Tomas J., |e author. | |
| 710 | 2 | |a American Enterprise Institute for Public Policy Research, |e issuing body. | |
| 830 | 0 | |a American Enterprise Institute library. | |
| 856 | 4 | 0 | |3 HeinOnline American Enterprise Institute Library |u http://ezp1.villanova.edu/login?url=https://www.heinonline.org/HOL/Page?handle=hein.amenin/aeiabmp0001&id=1&size=2&collection=amenin&index=alpha/I_ameninpubs |
| 949 | |a R 855.3 .J46 2008 |w LC |c 1 |i 950604-1001 |d 9/29/2020 |l MAIN |m HEN |q 1 |r Y |s Y |t WEB |u 9/28/2020 |x ENG | ||
| 997 | |a ©2020 Cassidy Cataloguing Services, Inc. | ||
| 998 | |a inter | ||
| 999 | |c 324544 | ||
| 852 | |a Law Library |b online | ||